Member Info for Newuncle

Biker,

Market is still moving only on sells, buys get ignored so SPs will move down. MMs being dicks here as they clearly don't want to take shares on but the more they drop prices the more people will sell. Bit like the BoE raising interest rates to combat inflation but instead all they will do is deepen economic decline instead. Seems like no one who makes these decisions knows what they are doing these days.

Not today but it's coming....

Smeeno,

For the financially unwashed types like me can you help explain how the share price target of 95p is achievable as I can't make much sense of TPs DCF modelling and their previous (now outdated) key assumptions. If I talk about a target price I like to think it's doable over say 12 months. What are TP actually saying terms of time when it comes to their 95p target price and on what basis?

The more and more I look at TP's note and how they got to to their target price the more interesting it gets. In it TP are quoting an equity value of £204.3 million based on a current 215.2 million ordinary shares in issue indicates a new price target of 94.7p. However, at the time it was produced there were assumptions that both PD Units and STC Kits would be sold outright e.g STC kit sold for something around £175 each based on sales of 20,000 per month + BT sales.

" News releases that might be expected to anticipate this include, amongst other things,
widespread regulatory imposition by European governments of real-time virus/pathogen
detection in water/wastewater potentially in tandem with formalisation of DeepVerge’s
far-reaching joint venture with State-owned China Resources, which together present an
opportunity to kick-start extended product roll out across multiple jurisdictions in 2H
2021. These, along with STC’s full UK marketing launch prior to expanding into other
international territories, suggests Group activity levels are set to step up a gear in the
coming months, with the MHRA potentially also awarding Microtox® BT with a CE mark
toward the end of Q1 2022. Recognising the scale of the opportunities being presented,
TPI has updated its forecasts and financial model for DeepVerge, resulting in a higher
price target of 94.7p for the shares (up from 84.8p previously set on 11 January 2021). "

I can't recall if the TP note actually shows any kind of breakdown of the phenomenal growth and forecast of £24m for 2022 as far as I can recall it was based on pure financial modelling?

Looks like MSYS has found its new trading range (for the time being) and an orderly market seems to be working for now.

The other thing that amazes me with the stock market (and DVRG just one of many now) is how does £50m of value simply just evaporate from a plc so quickly? If that happened to house prices people would be rioting in the streets.

Media are in a frenzy about how hugely speculative, unsafe and unregulated BitCoin investors etc have lost @2/3 of their values this year and then I thought well how does DVRG compare as a regulated, listed plc.....oops, uh well at least this must be the bottom now at last?

Deepverge Plc Ord 0.1P is listed on the London Stock Exchange, trading with ticker code DVRG. It has a market capitalisation of £25m, with approximately 220m shares in issue. Over the last year, Deepverge share price has been traded in a range of 23.85, hitting a high of 34.85, and a low of 11.

and there goes Mr50k at 11.00.

11.02 taken on the bid just now so flirting going in to the 10s next. Have we ever been there before as DVRG, I know that we did as Skin all those years ago.

Ask is @ £0.000765 per share

Nothings really changed on the bid and the ask is @ £0.000722/share

Quote Sell 1,000,000 share(s) @ £0.000722/share

I remember holding these years ago when they had interests in a company called Pressfit Holdings (some sort of marine piping business or something like that and land in place like a beach near Rio in Brazil? Haven't followed them for absolute ages but just read a few RNSs and looks like they flipped everything and went all in on Swedish ecommerce start ups? Seems like the old management have continued with their very poor investing strategy here? How are they still running a plc?

Lots of buying today, no movement. Wouldn't surprise me if MMs have calls out to brokers for someone to sell a few in case any more buys show up.

Maybe Julian is waiting on some more recent data he can highlight in his forward looking statement?

Davey,

I have to agree, Turnover is Vanity, Profits are Sanity. Lots of fancy numbers in that update but of course nothing re profitability and when they can achieve that.

T

Thanks again for the very relevant info below let's hope Gerry can demonstrate if BT is suitable and ready to launch or why it's not and why. As you say hope we don't get a bland ongoing testing requirements or further development work needed.

T,

How do you recall all this stuff? So we should know more about progress with BT at least, way too early to talk about BT commercially I guess as testing for medical devices (I assume it's classed as medical device) can go on for a very long time.

Therefore, roll out of the breath test is subject to meeting the satisfactory requirements of EU Regulatory approvals which will be carried out on the latest version of the Microtox® BT units. Further information on this will be provided in H1 2022.

Choose your own appropriate words.......

MSYS should still deliver, from Jan 22 Trading Update:

Outlook

The Company has entered 2022 with a healthy sales opportunities pipeline. The Board is targeting a significant increase in revenues in 2022, underpinned by scientific services opportunities, particularly in bioprocessing and water markets, but also the extension of Microsaic's detection platform into Human and Environmental Health real-time monitoring. The Company continues to take a measured approach to market access with a keen focus on expenditure. Microsaic intends to grow its business in conjunction with partners, such as DeepVerge in water detection collaborations, with contract research organisations in bioprocessing, through the extension of its Chinese business with a range of local partners, and via OEM and other strategic partnerships under discussion.